CTLA4 Antikörper (N-Term) (APC)
Kurzübersicht für CTLA4 Antikörper (N-Term) (APC) (ABIN2287398)
Target
Alle CTLA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 57-86, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- IDDM12, NT (CTLA4, CD152, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152) (APC)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- IDDM12 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 57-86 amino acids from the N-terminal region of human IDDM12.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 4°C ,Do Not Freeze
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Andere Bezeichnung
- IDDM12
-
NCBI Accession
- NP_005205, NP_001032720
-
UniProt
- P16410
-
Pathways
- Cancer Immune Checkpoints
Target
-